Source: Pharmabiz

Origiin Ip Solutions: Origiin IP attributes shortfall of testing kits for COVID19 to longdrawn validation process

Origiin IP attributes the shortfall of testing kits for COVID─19 primarily due to the long─drawn validating processes. The situation is not just for India but globally too.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100